| 02/03 | PROMIS NEUROSCIENCES : Offers Perspectives on Recent Progress in the Alzheimer'.. | AQ |
| 02/02 | PROMIS NEUROSCIENCES : Edging Up After Offering Perspectives on Recent Progress.. | MT |
| 02/02 | PROMIS NEUROSCIENCES : Offers Perspectives on Recent Progress in the Alzheimer'.. | PU |
| 01/12 | PROMIS NEUROSCIENCES : Details Strategic Priorities for 2021 | MT |
| 01/12 | ProMIS Neurosciences Announces Strategic Priorities for 2021 | GL |
| 2020 | PROMIS NEUROSCIENCES : Year in review, looking forward to 2021 | PU |
| 2020 | PROMIS NEUROSCIENCES : Completes offering of special warrants | AQ |
| 2020 | PROMIS NEUROSCIENCES : Completes Offering of Special Warrants | AQ |
| 2020 | ProMIS Neurosciences Completes Offering of Special Warrants | GL |
| 2020 | PROMIS NEUROSCIENCES : Completes offering of special warrants | PU |
| 2020 | PROMIS NEUROSCIENCES : Announces Third Quarter 2020 Results | PU |
| 2020 | PROMIS NEUROSCIENCES : Announces Third Quarter 2020 Results | AQ |
| 2020 | PROMIS NEUROSCIENCES : Announces Third Quarter 2020 Results | AQ |
| 2020 | ProMIS Neurosciences Announces Third Quarter 2020 Results | GL |
| 2020 | PROMIS NEUROSCIENCES : Falls to Near 52-Week Low After FDA Committee Concludes .. | MT |
| 2020 | PROMIS NEUROSCIENCES : offers comments on recent FDA Advisory Committee meeting.. | PU |
| 2020 | PROMIS NEUROSCIENCES : offers comments on recent FDA Advisory Committee meeting.. | AQ |
| 2020 | PROMIS NEUROSCIENCES : offers comments on recent FDA Advisory Committee meeting.. | AQ |
| 2020 | ProMIS Neurosciences offers comments on recent FDA Advisory Committee meeting.. | GL |
| 2020 | PROMIS NEUROSCIENCES : Closes first tranche of private placement | PU |
| 2020 | PROMIS NEUROSCIENCES : Closes First Tranche of Private Placement | AQ |
| 2020 | ProMIS Neurosciences Closes First Tranche of Private Placement | GL |
| 2020 | PROMIS NEUROSCIENCES : Dr. Neil Cashman CSO, to Speak at 2020 ALS ONE Research .. | AQ |
| 2020 | PROMIS NEUROSCIENCES : adds Dr. David Wishart to its Scientific Advisory Board | AQ |
| 2020 | PROMIS NEUROSCIENCES : rsquo; Dr. Neil Cashman CSO, to Speak at 2020 ALS ONE Re.. | AQ |
| 2020 | PROMIS NEUROSCIENCES : rsquo; Dr. Neil Cashman CSO, to Speak at 2020 ALS ONE Re.. | AQ |
| 2020 | ProMIS Neurosciences' Dr. Neil Cashman CSO, to Speak at 2020 ALS ONE Research.. | GL |
| 2020 | PROMIS NEUROSCIENCES : adds Dr. David Wishart to its Scientific Advisory Board | PU |
| 2020 | PROMIS NEUROSCIENCES : adds Dr. David Wishart to its Scientific Advisory Board | AQ |
| 2020 | PROMIS NEUROSCIENCES : adds Dr. David Wishart to its Scientific Advisory Board | AQ |
| 2020 | ProMIS Neurosciences adds Dr. David Wishart to its Scientific Advisory Board | GL |
| 2020 | PROMIS NEUROSCIENCES : Announces up to $3 million private placement offering of.. | AQ |
| 2020 | PROMIS NEUROSCIENCES : Announces up to $3 million private placement offering of.. | PU |
| 2020 | PROMIS NEUROSCIENCES : Announces Up to $3 Million Private Placement Offering of.. | AQ |
| 2020 | ProMIS Neurosciences Announces Up to $3 Million Private Placement Offering of.. | GL |
| 2020 | PROMIS NEUROSCIENCES' PERSPECTIVE ON : is approval likely? | PU |
| 2020 | PROMIS NEUROSCIENCES : Offers its Perspective on the Likelihood of Regulatory A.. | AQ |
| 2020 | PROMIS NEUROSCIENCES : Offers its Perspective on the Likelihood of Regulatory A.. | AQ |
| 2020 | ProMIS Neurosciences Offers its Perspective on the Likelihood of Regulatory A.. | GL |
| 2020 | PROMIS NEUROSCIENCES : Neil Cashman to Speak at Protein Misfolding Drug Discove.. | AQ |
| 2020 | PROMIS NEUROSCIENCES : rsquo; Neil Cashman to Speak at Protein Misfolding Drug .. | AQ |
| 2020 | PROMIS NEUROSCIENCES : rsquo; Neil Cashman to Speak at Protein Misfolding Drug .. | AQ |
| 2020 | ProMIS Neurosciences' Neil Cashman to Speak at Protein Misfolding Drug Disco.. | GL |
| 2020 | PROMIS NEUROSCIENCES : to develop multivalent vaccine for Alzheimer's disease | AQ |
| 2020 | PROMIS NEUROSCIENCES : to develop multivalent vaccine for Alzheimer's disease | PU |
| 2020 | PROMIS NEUROSCIENCES : to develop multivalent vaccine for Alzheimer's disease | AQ |
| 2020 | PROMIS NEUROSCIENCES : to develop multivalent vaccine for Alzheimer's disease | AQ |
| 2020 | ProMIS Neurosciences to develop multivalent vaccine for Alzheimer's disease | GL |
| 2020 | PROMIS NEUROSCIENCES : to Participate in H.C. Wainwright & Co. 22nd Annual Inve.. | AQ |
| 2020 | PROMIS NEUROSCIENCES : to Participate in H.C. Wainwright & Co. 22nd Annual Inve.. | AQ |
| 2020 | ProMIS Neurosciences to Participate in H.C. Wainwright & Co. 22nd Annual Inve.. | GL |
| 2020 | ProMIS Neurosciences Announces Second Quarter 2020 Results | GL |
| 2020 | PROMIS NEUROSCIENCES : CEO memorandum to ProMIS shareholders, August 11, 2020 | PU |
| 2020 | ProMIS Neurosciences Announces Results of Annual Meeting of Shareholders | GL |
| 2020 | PROMIS NEUROSCIENCES : and BC Neuroimmunology announce revenue-sharing joint ve.. | AQ |
| 2020 | ProMIS Neurosciences and BC Neuroimmunology announce revenue-sharing joint ve.. | GL |
| 2020 | ProMIS Neurosciences announces adjournment and change of location of annual m.. | GL |
| 2020 | ProMIS Neurosciences and collaborator BC Neuroimmunology announce significant.. | GL |
| 2020 | ProMIS Neurosciences and collaborative team receive Supercluster Award suppor.. | GL |
| 2020 | PROMIS NEUROSCIENCES : Chairman's Update details new programs from expanded use.. | AQ |
| 2020 | PROMIS NEUROSCIENCES : and BC Neuroimmunology expand collaboration to develop a.. | AQ |
| 2020 | PROMIS NEUROSCIENCES : Chairman's Memorandum, May 20, 2020 | PU |
| 2020 | ProMIS Neurosciences Chairman's Update details new programs from expanded use.. | GL |
| 2020 | ProMIS Neurosciences and BC Neuroimmunology expand collaboration to develop a.. | GL |
| 2020 | ProMIS Neurosciences Announces First Quarter 2020 Results | GL |
| 2020 | ProMIS Neurosciences identifies multiple novel targets on SARS CoV-2 for deve.. | GL |
| 2020 | ProMIS Neurosciences develops novel antagonists for RACK1, a protein involved.. | GL |
| 2020 | ProMIS Neurosciences creates novel intrabodies for ALS, frontotemporal dement.. | GL |
| 2020 | PROMIS NEUROSCIENCES : commends Biogen for clarifying aducanumab regulatory fil.. | AQ |
| 2020 | ProMIS Neurosciences announces collaboration to develop serological test to a.. | GL |
| 2020 | PROMIS NEUROSCIENCES : Journal of the American Academy of Neurology Publishes P.. | AQ |
| 2020 | PROMIS NEUROSCIENCES : Journal of the American Academy of Neurology Publishes P.. | AQ |
| 2020 | Journal of the American Academy of Neurology Publishes ProMIS Neurosciences' .. | GL |
| 2020 | ProMIS Neurosciences to Present Data and Moderate Session at AAIC 2020 | GL |
| 2020 | PROMIS NEUROSCIENCES : Announces approval for warrant repricing | AQ |
Canada
Deutschland
España
France
Italia
Schweiz (DE)
United Kingdom
Report
